(PDF) Thrombospondin-1 Is a Critical Effector of

Thrombospondin-1 Is a Critical Effector of Oncosuppressive Activity of Sst2 Somatostatin Receptor on Pancreatic Cancer

Proceedings of the National Academy of Sciences of the United States of America - United States

doi 10.1073/pnas.0908674106

Full Text

Abstract

Available in full text

Categories

Multidisciplinary

Date

October 1, 2009

Authors

Publisher

Proceedings of the National Academy of Sciences

Related search

Rat Somatostatin Sst2(a)and Sst2(b)receptor Isoforms Mediate Opposite Effects on Cell Proliferation

British Journal of Pharmacology

English

Early Cerebral Activities of the Environmental Estrogen Bisphenol a Appear to Act via the Somatostatin Receptor Subtype Sst2

Environmental Health Perspectives

Occupational Health

English

Thrombospondin-1 Is a Transcriptional Repression Target of PRMT6

Journal of Biological Chemistry

Molecular Biology

English

Is Physical Activity a Protective Factor Against Pancreatic Cancer?

Bratislava Medical Journal

English

The Thrombospondin-1 Receptor CD36 Is an Important Mediator of Ovarian Angiogenesis and Folliculogenesis

Reproductive Biology and Endocrinology

Reproductive Medicine

Developmental Biology

English

Stem Cell Marker Nestin Is Critical for TGF- 1-Mediated Tumor Progression in Pancreatic Cancer

Molecular Cancer Research

Cancer Research

Molecular Biology

English

Activation of D1 and D2 Dopamine Receptors Increases the Activity of the Somatostatin Receptor-Effector System in the Rat Frontoparietal Cortex

Journal of Neuroscience Research

Molecular Neuroscience

English

Comment On: Somatostatin Receptor SPECT

European Journal of Nuclear Medicine and Molecular Imaging

Nuclear Medicine

English

Somatostatin-Receptor Scintigraphy in Primary Breast Cancer

English